|
2
|
27
|
1ypgL |
Thrombin inhibitor complex |
|
59
|
257
|
1ypmH |
X-ray crystal structure of thrombin inhibited by synthetic cyanopeptide analogue ra-1014 |
|
58
|
257
|
1ypjH |
Thrombin inhibitor complex |
|
12
|
146
|
1ycpK |
The crystal structure of fibrinogen-aa peptide 1-23 (f8y) bound to bovine thrombin explains why the mutation of phe-8 to tyrosine strongly inhibits normal cleavage at arginine-16 |
|
58
|
257
|
1ypgH |
Thrombin inhibitor complex |
|
3
|
27
|
1ypeL |
Thrombin inhibitor complex |
|
3
|
31
|
1xmnA |
Crystal structure of thrombin bound to heparin |
|
65
|
287
|
1xm1A |
Nonbasic thrombin inhibitor complex |
|
60
|
258
|
1xmnB |
Crystal structure of thrombin bound to heparin |
|
3
|
26
|
1w7gL |
Alpha-thrombin complex with sulfated hirudin (residues 54-65) and l- arginine template inhibitor cs107 |
|
3
|
29
|
1wayA |
Active site thrombin inhibitors |
|
60
|
250
|
1vzqH |
Complex of thrombin with designed inhibitor 7165 |
|
3
|
31
|
1wbgA |
Active site thrombin inhibitors |
|
3
|
27
|
1vr1L |
Specifity for plasminogen activator inhibitor-1 |
|
57
|
258
|
1w7gH |
Alpha-thrombin complex with sulfated hirudin (residues 54-65) and l- arginine template inhibitor cs107 |
|
59
|
259
|
1wayB |
Active site thrombin inhibitors |
|
2
|
27
|
1vzqL |
Complex of thrombin with designed inhibitor 7165 |
|
58
|
259
|
1wbgB |
Active site thrombin inhibitors |
|
1
|
36
|
1vitL |
Thrombin:hirudin 51-65 complex |
|
16
|
109
|
1vitG |
Thrombin:hirudin 51-65 complex |
|
55
|
259
|
1vr1H |
Specifity for plasminogen activator inhibitor-1 |
|
14
|
150
|
1vitF |
Thrombin:hirudin 51-65 complex |
|
43
|
259
|
1vitH |
Thrombin:hirudin 51-65 complex |
|
0
|
24
|
1uvuL |
Bovine thrombin--bm12.1700 complex |
|
44
|
254
|
1uvuH |
Bovine thrombin--bm12.1700 complex |
|
56
|
259
|
1umaH |
Alpha-thrombin (hirugen) complexed with na-(n,n-dimethylcarbamoyl)-alpha-azalysine |
|
47
|
254
|
1uvsH |
Bovine thrombin--bm51.1011 complex |
|
2
|
36
|
1umaL |
Alpha-thrombin (hirugen) complexed with na-(n,n-dimethylcarbamoyl)-alpha-azalysine |
|
52
|
255
|
1uvtH |
Bovine thrombin--bm14.1248 complex |
|
0
|
25
|
1uvtL |
Bovine thrombin--bm14.1248 complex |
|
2
|
27
|
1uvsL |
Bovine thrombin--bm51.1011 complex |
|
18
|
150
|
1ucyH |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
21
|
109
|
1ucyE |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
3
|
36
|
1ucyJ |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
56
|
259
|
1ucyK |
Thrombin complexed with fibrinopeptide a alpha (residues 7-19). three complexes, one with epsilon-thrombin and two with alpha-thrombin |
|
58
|
257
|
1tmtH |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms |
|
57
|
259
|
1thrH |
Structures of thrombin complexes with a designed and a natural exosite inhibitor |
|
3
|
26
|
1thrL |
Structures of thrombin complexes with a designed and a natural exosite inhibitor |
|
3
|
31
|
1tq0A |
Crystal structure of the potent anticoagulant thrombin mutant w215a/e217a in free form |
|
55
|
259
|
1twxB |
Crystal structure of the thrombin mutant d221a/d222k |
|
3
|
44
|
1tq7A |
Crystal structure of the anticoagulant thrombin mutant w215a/e217a bound to ppack |
|
56
|
259
|
1tmbH |
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide a |
|
52
|
257
|
1thpB |
Structure of human alpha-thrombin y225p mutant bound to d-phe-pro-arg-chloromethylketone |
|
49
|
259
|
1tocB |
Structure of serine proteinase |
|
2
|
28
|
1tmuL |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms |
|
1
|
27
|
1thpA |
Structure of human alpha-thrombin y225p mutant bound to d-phe-pro-arg-chloromethylketone |
|
50
|
257
|
1tq7B |
Crystal structure of the anticoagulant thrombin mutant w215a/e217a bound to ppack |
|
60
|
257
|
1tmuH |
Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms |
|
3
|
29
|
1tmbL |
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide a |
|
57
|
259
|
1thsH |
Structures of thrombin complexes with a designed and a natural exosite inhibitor |
